Related Experiment Video
Updated: Apr 5, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
13.4K
Update on CD40 and CD154 blockade in transplant models.
Tianshu Zhang1, Richard N Pierson1,2, Agnes M Azimzadeh1
1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Immunotherapy
|August 14, 2015
Summary
Effective immune responses need two signals. The CD40/CD154 costimulation pathway is crucial for adaptive immunity and shows promise for transplantation therapies.
Area of Science:
- Immunology
- Transplantation Science
Background:
- Effective immune responses require primary (T-cell receptor/peptide-MHC) and secondary (costimulatory) signals.
- The CD40/CD154 pathway is a key costimulatory pathway modulating adaptive immunity.
Purpose of the Study:
- To review the role of the CD40/CD154 costimulation pathway in alloimmunity.
- To summarize recent advances in therapeutic strategies targeting CD40/CD154 in transplantation.
Main Methods:
- Literature review of current understanding.
- Summary of mechanistic and preclinical data on CD40/CD154 targeting.
Main Results:
- The CD40/CD154 pathway plays a significant role in alloimmune responses.
- Therapeutic targeting of CD40/CD154 is being actively investigated for transplantation.
Conclusions:
- Understanding CD40/CD154 costimulation is vital for improving transplant outcomes.
- Targeting this pathway offers potential therapeutic benefits in preventing transplant rejection.
